Rising Rates Of C.Difficile Infection Among Non-Hospitalized Patients
Report of the rising rates of infection with C.difficile among the gen... The high incidence of the infection even among non-hospitalized p...The researchers examined a large database for identification of C....Infection with the microorganism is most commonly hospital acquire...The consumption of antibiotics destroys the natural bacterial flor...
Report of the rising rates of infection with C.difficile among the general public has led to concerns regarding the mutation of the microorganism into a more virulent form.// It was previously thought that the infection could only manifest in individuals with resistance to antibiotics.
The high incidence of the infection even among non-hospitalized patients has created much panic among the scientific community. "That is really a remarkably high increase in cases. "I think this needs verification in another database, to tell you the truth. And it may be that it's true. And it may be that there's something going on, " said Dr. Dale Gerding, a leading U.S. expert in the field.
The researchers examined a large database for identification of C. difficile infected cases in Britain. Surprisingly, the individuals identified did not have a positive history of hospital admission the previous year. The results of the present study have been presented in the Journal of the American Medical Association.
Infection with the microorganism is most commonly hospital acquired with a majority of the cases occurring within health-care facilities. High rates of antibiotic usage and the difficulty to eradicate the sporocytic form of C. difficile are some of the factors believed to account for the high rates of infection in hospitals.
The consumption of antibiotics destroys the natural bacterial flora present in the intestine, and enhances the susceptibility to the infection. C.difficile now happily grows and thrives in an otherwise hostile environment leading to symptoms such as severe diarrhea, abdominal pain, and fever.
An alarming rate of the infection incidence in Britain from 1 to 22 cases per 100, 000 has been found during the 10-year period (1994- 2004). Out of this, only 37% of the infected individuals had taken antibiotics prior to the infection episode.
In addition it was found that those taking Nexium (pro '"/>
(Date:12/2/2009)... 2 US Farms, Inc. (Pink ...Nursery and Wellness products, is pleased to annou... at the Cook,sware A,faire in Oakland, Calif., at ... additional information, contact US Farms, Inc. Cu... http://cookswareafaire.com ,, Victor Brandst...
(Date:12/2/2009)...DMOND, Wash., Dec. 2 /PRNewswire/ -- Golden Li...ill collaborate to give caregivers single-point ac...ry for providing ongoing care after patients leave...ies better tools for managing patients, health. ,...anization to adopt Microsoft Amalga Unified Intell...
(Date:12/2/2009)...generation is not advised, expert says , ...o take low-dose aspirin to protect their heart mig... by Harvard University researchers found what they...enting age-related macular degeneration (AMD), an ..., "The data indicate that long-term treatment wi...
(Date:12/2/2009)...ewswire-USNewswire/ -- ,, Expert Panel to Dis... ,, A special press briefing will be held Wedne...aturing a panel of top experts who will discuss th...TF) release of revised screening mammography guide...ical experts and government authorities dispute th...
(Date:12/2/2009)...imation detailing plastic surgery procedures is no...ical candidates can view procedures and print out ... (PRWEB) December 2, 2009 -...s retailer, has always been dedicated to providing...r procedures, providing liposuction garments, brea...
...ILLE, Tenn., Feb. 22 HCA Inc. announced today the...debt tender offer to,purchase up to $500 million o... ("Notes"). The tender offer is being made on the ... identifies the Notes that are the subject of the ...
..., Joe and Nick Jonas Kick-Off Campaign with Launch...n the New Breakfast BREAKS TV Commercial,Jonas Bro...ool with Concert to Announce New Breakf..., the,Jonas Brothers, for a national campaign to r...
...it Cogon at HIMSS - Bo...FL-based Cogon,Systems, Inc. is excited to announc...rnet-based health information exchange platform, t...a. In the coming year,Cogon Systems, Inc. has been...
...is conference will use a cross-disciplinary approa...ural products and their prospects for continued co...view of recent developments impacting the discover...operation, bioinformatics, etc., will be discussed...
...orto-duodenal fistulae (ADF) are the most frequent...t presenting sign of ADF is upper gastrointestinal...nderwent an aortic-bi-femoral bypass five years ag...can showed in the third duodenal segment the prese...
...flammatory bowel disease (IBD) is a chronic recurr...latively higher morbidity in young adults, in whom...re adversely influenced. A number of guidelines fo...he actual quality of care for patients with IBD in...
(Date:12/1/2009)... Reportlinker.com announces that a...talogue: ,, HPLC Systems & Accessories - A...er.com/p0164366/HPLC-Systems--Accessories---A-Worl... Chromatography has emerged as a workhorse technol...verage, research and development, and industrial c...
(Date:12/1/2009)...J., Dec. 1 Merck & Co., Inc. t...tration (FDA) has approved ZEGERID OTC(TM) (omepra...or over-the-counter treatment of frequent heartbur...by Schering-Plough HealthCare Products, Inc., the ...nc. Schering-Plough and Merck merged on November 3...
(Date:12/1/2009)... Reportlinker.com announces that a...talogue: ,, Direct to Consumer (DTC) Advertisi...Outlook, Regulatory Landscape and Case Studies ,...o-Consumer-DTC-Advertising-in-Pharmaceuticals---Cu...pe-and-Case-Studies.html ,, Summary ,, Th...
...,Bulletin Board: GOVX), an Atlanta based biotechno... immunogenicity data from its full-dose HIV/AIDS,v... This full-dose trial is the second in a series of...fety and immunogenicity of the GeoVax,HIV/AIDS vac...ved vaccine,and 6 received placebo, this trial pro...
...nce,Applications International Corporation (NYSE: ...act extension by the National Institute of Allergy...obiology and Infectious,Diseases (DMID), part of t...ia vaccine production and support services. The s...mated value of,$32.7 million. The contract extensi...